Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» November 2011
November 2011
Medivation Back to Neutral
Medivation Back to Neutral
Yahoo/Zacks
Medivation
MDV3100
prostate cancer
Inhibitex: The Negatives Of An Acquisition And The Odds Of It Occurring
Inhibitex: The Negatives Of An Acquisition And The Odds Of It Occurring
Seeking Alpha
Inhibitex
4-Star Stocks Poised to Pop: Sequenom
4-Star Stocks Poised to Pop: Sequenom
Motley Fool
Sequenom
Looking back at Immunex and ahead to Seattle's biotech future
Looking back at Immunex and ahead to Seattle's biotech future
bizjournals.com
Amgen
Transcept Wins FDA OK For Insomnia Drug, What's Next?
Transcept Wins FDA OK For Insomnia Drug, What's Next?
Seeking Alpha
Transcept
FDA
insomnia
Intermezzo
DEALTALK-Pfizer likely to spin off animal health -sources
DEALTALK-Pfizer likely to spin off animal health -sources
Reuters
Pfizer
M&A
animal health
Obama’s Medicare Chief Plans to Resign
Obama’s Medicare Chief Plans to Resign
Bloomberg
Obama
Medicare
Medicaid
Chronic Bowel Disease Drugs Linked to Skin Cancer Risk
Chronic Bowel Disease Drugs Linked to Skin Cancer Risk
Yahoo/Health Day
thiopurines
skin cancer
inflammatory bowel disease
Bayer YAZ To Follow Merck's Vioxx?
Bayer YAZ To Follow Merck's Vioxx?
Injuryboard.com
Merck
Yaz
Yasmin
Vioxx
Why Pfizer May Be About to Take Off
Why Pfizer May Be About to Take Off
Motley Fool
Pfizer
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »